Advertisement

Annals of Surgical Oncology

, Volume 23, Issue 6, pp 2079–2086 | Cite as

Blood Loss and Transfusion Requirements in Metastatic Spinal Tumor Surgery: Evaluation of Influencing Factors

  • Naresh Kumar
  • Aye Sandar Zaw
  • Hnin Ei Khine
  • Karthikeyan Maharajan
  • Khin Lay Wai
  • Barry Tan
  • Siti Mastura
  • Raymond Goy
Neuro-Oncology

Abstract

Background

Metastatic spine tumor surgery (MSTS) can be associated with significant blood loss. Previous studies did not provide comprehensive data on blood loss in MSTS. Thorough study elaborating the blood loss, transfusion requirement, and their influencing factors is required. This study aimed to investigate the estimated blood loss and transfusion requirements associated with various surgical approaches and surgically managed vertebral levels for spinal metastases from different primary tumors.

Methods

The study retrospectively evaluated 243 patients who underwent surgery for metastatic spine tumors at the authors’ institution between 2005 and 2014. Estimated intraoperative blood loss and transfusion requirement were assessed for different primary tumors including lung, breast, prostate, gastrointestinal, renal, liver, thyroid, myeloma/lymphoma, and others; types of surgical procedure (cervical corpectomy ± stabilization, thoracolumbar posterior decompression ± instrumentation, thoracolumbar corpectomy, minimally invasive surgery); and levels of instrumentation and decompression. Multivariate linear regression was attempted to investigate the factors influencing blood loss and transfusion requirements.

Results

The mean blood loss was 870 ± 720 ml, and the average blood transfusion was 1.5 ± 1.9 U. The mean blood loss was 1103 ml for patients who received blood transfusion and 597 ml for those who did not. Multivariate analysis showed that the significant factors influencing blood loss were primary tumor, type of surgery, and prolonged operative time. The influencing factors for blood transfusion were primary tumor, type of surgery, preoperative hemoglobin, and prolonged operative time.

Conclusions

Significant variations in blood loss and transfusion requirement were based on primary tumor of spinal metastases, surgical approaches, and operative time. These findings will help clinicians in preoperative planning to address the problem of blood loss during MSTS.

Keywords

Blood Loss Tranexamic Acid Minimally Invasive Surgery Transfusion Requirement Spinal Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

We thank A/Prof Gabriel Liu, A/Prof Joseph Thambiah, A/Prof Hwan Tak Hee and Prof Hee-Kit Wong for contributing the cases. We also thank Chan Ee, K Perini, Amreet Kaur, Amanda, Yi Linn and Hilary for their contribution in data collection of the spine tumour patients.

Conflict of interest

There are no conflicts of interest.

Disclosure

None.

References

  1. 1.
    Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Jt J. 2013;95-B:683–8.CrossRefGoogle Scholar
  2. 2.
    Holman PJ, Suki D, McCutcheon I, Wolinsky JP, Rhines LD, Gokaslan ZL. Surgical management of metastatic disease of the lumbar spine: experience with 139 patients. J Neurosurg Spine. 2005;2:550–63.CrossRefPubMedGoogle Scholar
  3. 3.
    Xu R, Garces-Ambrossi GL, McGirt MJ, et al. Thoracic vertebrectomy and spinal reconstruction via anterior, posterior, or combined approaches: clinical outcomes in 91 consecutive patients with metastatic spinal tumors. J Neurosurg Spine. 2009;11:272–84.CrossRefPubMedGoogle Scholar
  4. 4.
    Schmidt R, Rupp-Heim G, Dammann F, Ulrich C, Nothwang J. Surgical therapy of vertebral metastases: are there predictive parameters for intraoperative excessive blood loss despite preoperative embolization? Tumori. 2011;97:66–73.PubMedGoogle Scholar
  5. 5.
    Kouritas V, Graham S, Marwah G, Papastefanou SL. Can we reduce routine blood ordering in spinal surgery? Transfus Altern Transfus Med. 2010;11:138–42.CrossRefGoogle Scholar
  6. 6.
    Kumar N, Zaw AS, Reyes MR, et al. Versatility of percutaneous pedicular screw fixation in metastatic spine tumor surgery: a prospective analysis. Ann Surg Oncol. 2015;22:1604–11.CrossRefPubMedGoogle Scholar
  7. 7.
    Bilsky MH, Fraser JF. Complication avoidance in vertebral column spine tumors. Neurosurg Clin N Am. 2006;17:317–29-vii.Google Scholar
  8. 8.
    Hu SS. Blood loss in adult spinal surgery. Eur Spine J. 2004;13(Suppl 1):S3–5.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus. 2001;11:e10.CrossRefPubMedGoogle Scholar
  10. 10.
    Abe E, Kobayashi T, Murai H, Suzuki T, Chiba M, Okuyama K. Total spondylectomy for primary malignant, aggressive benign, and solitary metastatic bone tumors of the thoracolumbar spine. J Spinal Disord. 2001;14:237–46.CrossRefPubMedGoogle Scholar
  11. 11.
    Chen YJ, Chang GC, Chen HT, et al. Surgical results of metastatic spinal cord compression secondary to non-small cell lung cancer. Spine Phila 1976. 2007;32:E413–8.Google Scholar
  12. 12.
    Cho DC, Sung JK. Palliative surgery for metastatic thoracic and lumbar tumors using posterolateral transpedicular approach with posterior instrumentation. Surg Neurol. 2009;71:424–33.CrossRefPubMedGoogle Scholar
  13. 13.
    Street J, Fisher C, Sparkes J, et al. Single-stage posterolateral vertebrectomy for the management of metastatic disease of the thoracic and lumbar spine: a prospective study of an evolving surgical technique. J Spinal Disord Technol. 2007;20:509–20.CrossRefGoogle Scholar
  14. 14.
    Tanaka M, Nakahara S, Ito Y, et al. Surgical treatment of metastatic vertebral tumors. Acta Med Okayama. 2009;63:145–50.PubMedGoogle Scholar
  15. 15.
    Olerud C, Jonsson H Jr, Lofberg AM, Lorelius LE, Sjostrom L. Embolization of spinal metastases reduces peroperative blood loss: 21 patients operated on for renal cell carcinoma. Acta Orthop Scand. 1993;64:9–12.CrossRefPubMedGoogle Scholar
  16. 16.
    Berkefeld J, Scale D, Kirchner J, Heinrich T, Kollath J. Hypervascular spinal tumors: influence of the embolization technique on perioperative hemorrhage. AJNR Am J Neuroradiol. 1999;20:757–63.PubMedGoogle Scholar
  17. 17.
    Manke C, Bretschneider T, Lenhart M, et al. Spinal metastases from renal cell carcinoma: effect of preoperative particle embolization on intraoperative blood loss. AJNR Am J Neuroradiol. 2001;22:997–1003.PubMedGoogle Scholar
  18. 18.
    Deutsch H, Boco T, Lobel J. Minimally invasive transpedicular vertebrectomy for metastatic disease to the thoracic spine. J Spinal Disord Technol. 2008;21:101–5.CrossRefGoogle Scholar
  19. 19.
    Scheufler KM. Technique and clinical results of minimally invasive reconstruction and stabilization of the thoracic and thoracolumbar spine with expandable cages and ventrolateral plate fixation. Neurosurgery. 2007;61:798–808 (Discussion 808–799).CrossRefPubMedGoogle Scholar
  20. 20.
    Lau D, Chou D. Posterior thoracic corpectomy with cage reconstruction for metastatic spinal tumors: comparing the mini-open approach to the open approach. J Neurosurg Spine. 2015;23:217–27.CrossRefPubMedGoogle Scholar
  21. 21.
    Alshryda S, Mason J, Sarda P, et al. Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total hip replacement: a randomized controlled trial (TRANX-H). J Bone Jt Surg Am. 2013;95:1969–74.CrossRefGoogle Scholar
  22. 22.
    Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Jt Surg Br Vol. 2011;93:39–46.CrossRefPubMedGoogle Scholar
  23. 23.
    Badeaux J, Hawley D. A systematic review of the effectiveness of intravenous tranexamic acid administration in managing perioperative blood loss in patients undergoing spine surgery. J Perianesthes Nurs. 2014;29:459–65.CrossRefGoogle Scholar
  24. 24.
    Zhang F, Wang K, Li FN, et al. Effectiveness of tranexamic acid in reducing blood loss in spinal surgery: a meta-analysis. BMC Musculoskelet Disord. 2014;15:448.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Clausen C, Dahl B, Frevert SC, Hansen LV, Nielsen MB, Lonn L. Preoperative embolization in surgical treatment of spinal metastases: single-blind, randomized controlled clinical trial of efficacy in decreasing intraoperative blood loss. JVIR J Vasc Interv Radiol. 2015;26:402–12; e401.Google Scholar
  26. 26.
    Kawai A, Kadota H, Yamaguchi U, Morimoto Y, Ozaki T, Beppu Y. Blood loss and transfusion associated with musculoskeletal tumor surgery. J Surg Oncol. 2005;92:52–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Blajchman MA, Bordin JO. The tumor growth-promoting effect of allogeneic blood transfusions. Immunol Investig. 1995;24:311–7.CrossRefGoogle Scholar
  28. 28.
    Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol. 1997;34(3 Suppl 2):34–40.PubMedGoogle Scholar
  29. 29.
    Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol. 2014;21:2436–43.CrossRefPubMedGoogle Scholar
  30. 30.
    Kumar N, Ahmed Q, Lee VK, Zaw AS, Goy R, Wong HK. Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery? Eur Spine J. 2015. doi: 10.1007/s00586-015-4112-x.
  31. 31.
    Kumar N, Chen Y, Nath C, Liu EH. What is the role of autologous blood transfusion in major spine surgery? Am J Orthop Belle Mead NJ 2012;41:E89–95.PubMedGoogle Scholar
  32. 32.
    Kumar N, Chen Y, Zaw AS, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 2014;15:e33–41.CrossRefPubMedGoogle Scholar
  33. 33.
    Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol. 2014;21:4330–5.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2016

Authors and Affiliations

  • Naresh Kumar
    • 1
  • Aye Sandar Zaw
    • 1
  • Hnin Ei Khine
    • 1
  • Karthikeyan Maharajan
    • 1
  • Khin Lay Wai
    • 2
  • Barry Tan
    • 1
  • Siti Mastura
    • 1
  • Raymond Goy
    • 3
  1. 1.Department of Orthopaedic SurgeryNational University Health SystemSingaporeSingapore
  2. 2.Investigational Medicine UnitNational University Health SystemSingaporeSingapore
  3. 3.Department of AnaesthesiaNational University Health SystemSingaporeSingapore

Personalised recommendations